Research paperThe mitochondrial F1FO-ATPase desensitization to OLIGOMYCIN (cas 1404-19-9) by tributyltin is due to thiol oxidation
-
Add time:09/04/2019 Source:sciencedirect.com
The antibiotic OLIGOMYCIN (cas 1404-19-9) is known to inhibit mitochondrial F-type ATP synthases. The antibiotic inhibits both ATP synthesis and hydrolysis by blocking the H+ translocation through FO which is coupled to the catalytic activity of F1. The amphiphilic organotin tri-n-butyltin (TBT), a known mitochondrial poison, can penetrate into biological membranes and covalently bind to electron-donor atoms of biomolecules such as sulfur. This study aims at exploring the mechanism(s) involved in the enzyme desensitization to oligomycin which occurs at concentrations >1 μM TBT. This poorly known effect of TBT, which only appeared at temperatures above the break in the Arrhenius plot of the enzyme activity, was found to be accompanied by the oxidation of isolated thiol groups of the mitochondrial complex. The oligomycin sensitivity was restored by the reducing agents glutathione and dithioerythritol and not influenced by antioxidants. The whole of data is consistent with the hypothesis that thiol oxidation is caused by TBT covalent binding to cysteine residues in a low-affinity site on FO and not by other possible oxidative events. According to this putative model, the onset of tin–sulfur bonds would trigger conformational changes and weaken the oligomycin interaction with FO.
We also recommend Trading Suppliers and Manufacturers of OLIGOMYCIN (cas 1404-19-9). Pls Click Website Link as below: cas 1404-19-9 suppliers
Prev:Original article/Article originalOLIGOMYCIN (cas 1404-19-9)s A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil
Next:Full PaperOLIGOMYCIN (cas 1404-19-9), an F1FO-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from OLIGOMYCIN (cas 1404-19-9) A09/08/2019
- OLIGOMYCIN (cas 1404-19-9) A and the IPLB-LdFB insect cell line: Actin and mitochondrial responses09/07/2019
- Research ArticleA comparative study of the single crystal X-ray determination and molecular modelling of the binding of OLIGOMYCIN (cas 1404-19-9) to ATP Synthase09/06/2019
- Full PaperOLIGOMYCIN (cas 1404-19-9), an F1FO-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats09/05/2019
- Original article/Article originalOLIGOMYCIN (cas 1404-19-9)s A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil09/03/2019
- Synthesis and cytotoxicity of OLIGOMYCIN (cas 1404-19-9) A derivatives modified in the side chain09/02/2019
- ReviewModifiers of the OLIGOMYCIN (cas 1404-19-9) sensitivity of the mitochondrial F1F0-ATPase09/01/2019